SILO PHARMA, INC. Notes Payable
SILO PHARMA, INC. (SILO) had Notes Payable of $18.90 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable › Notes Payable
us-gaap:NotesPayable · last filed 2021-11-10
- 2021-09-30: Notes Payable $18.90K.
- 2021-06-30: Notes Payable $18.90K.
- 2013-12-31: Notes Payable $15.00K.
- 2012-12-31: Notes Payable $20.00K.
| Period end | Notes Payable |
|---|---|
| 2021-09-30 | $18.90K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $18.90K 10-Q · filed 2021-08-13 |
| 2013-12-31 | $15.00K 10-K · filed 2014-03-31 |
| 2012-12-31 | $20.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |